Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CSL:AU

91.1200 AUD 0.5200 0.57%

As of 02:10:31 ET on 05/22/2015.

Company Profile for CSL Ltd (CSL)

CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.

Contact Information

CSL Ltd

45 Poplar Road
Parkville, VIC 3052
Australia
Phone: 61-3-9389-1911
Fax: 61-3-9389-1434

Key Executives for CSL Ltd (CSL)

John ShineChairmanPaul PerreaultCEO/Managing Director
Gordon NaylorChief Financial OfficerMary SontropExec VP:Manufacturing
Gregory Boss "Greg"Exec VP:Legal/Gen CnslKaren EtchbergerExec VP:Quality & Busi Service
Bob RepellaExec VP:Global Commercial OpsLaurie CowanSenior VP:Human Resourees
Mark DehringDir:Investor RelationsEdward H Bailey "Ed"Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil